Octopath AI

Timeline

• 2026-11-02UCL spin-out Octopath AI raises a £1 million seed led by Twin Path Ventures, plus a matched £500,000 Innovate UK grantCapital

People

Only people the AI4S.fyi record has named: in a round, a timeline entry, commentary, an interview or a sourced role. Not the full team.

Funding rounds tracked

• 2026-11-02Seed · £1M seed, with a £500k Innovate UK grant matched to it: £1.5M in allconfirmedLed by Twin Path VenturesStated use: clinical evaluation, product development and work towards regulatory approval

Each round links to its line on the funding record, with its source.

Also in Biology data and tools on the funding board

The other companies the funding board files under the same field, latest round first. A list of what the record tracks, not a ranking or a market map.

• 2026-10-27OmabitSeed · $2MSoftware that analyses a drug developer's own preclinical, clinical and genomic data alongside published research: a scientist chooses the question in plain language and it runs the analysis and writes it up, starting with clinical development, biomarker and translational teams.
• 2026-10-26adsilicoSeries A · £10MA University of Leeds spinout whose Virtual Chimera platform builds virtual hearts and blood vessels from anonymised clinical scans with generative AI, then runs physics simulations of how a heart valve, stent or other implant behaves in each, across a population varied by age, sex, ethnicity, body size and disease.
• 2026-10-20Electric PlantSeed · $11.2MMakes electrodes and low-cost sensors that record a living plant's electrical signals from its stem or trunk, and Bombadil, a model trained on those signals across about a hundred species that estimates leaf stress measures such as photosynthetic efficiency and water stress, for farming, forestry and plant care.
• 2026-10-07RivercellSeed · $25MGenerates time-resolved, multimodal single-cell data on how human cells respond to drugs and genetic changes, on its own platform and automated wet lab, to train an 'AI virtual cell' model that predicts those responses.
• 2026-09-24Prevision MedicineSeed · $5.4MTests a patient's living tumour cells against 100+ drugs and combinations before treatment, with automated microscopy and image analysis, so oncologists can rank drugs by how selectively they kill cancer cells.
• 2026-09-23Basecamp ResearchSeries C · $140MCollects genetic data from nature through partnerships in over 30 countries, trains its EDEN models on it, and now uses them to design therapies, starting with in vivo cell therapy.

All 13 in this field →